Results 271 to 280 of about 7,007,196 (291)

Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample

Drug and Alcohol Dependence, 2017
Kenneth Feder, Brendan Saloner, Noa Krawczyk   +2 more
exaly  

Global opioid agonist treatment: a review of clinical practices by country

Addiction, 2020
Matthew Hickman, Brandon Dl Marshall, Julie Bruneau   +2 more
exaly  

Pharmacology of Psychotropic Analgesic Nitrous Oxide as a Multipotent Opioid Agonist

International Journal of Neuroscience, 1994
F J Lichtigfeld, M A Gillman, Mark A Gillman   +2 more
exaly  

Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting

JAMA Internal Medicine, 2019
Amer, Raheemullah, Anna, Lembke
openaire   +2 more sources

Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review

International Journal of Infectious Diseases, 2016
Junkô Yasuoka, Bruno Sunguya
exaly  

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study

Frontiers in Psychiatry, 2020
Norbert Konrad, Annette Opitz-Welke
exaly  

The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist

Molecules, 2017
Roberto Sudo, Fernando de Carvalho da Silva, Vitor Ferreira   +2 more
exaly  

Kappa-opioid receptor agonists in pain treatment

Drugs of the Future, 2019
null Pergolizzi, J.V. Jr., null LeQuang, J.A., null Taylor, R. Jr., null Ossipov, M.H., null Raffa, R.B.   +4 more
openaire   +1 more source

GR94839, a κ‐opioid agonist with limited access to the central nervous system, has antinociceptive activity

British Journal of Pharmacology, 1992
A G Hayes
exaly  

A COMBINATION OF AN OPIOID AGONIST AND AN OPIOID ANTAGONIST IN THE TREATMENT OF PARKINSON'S DISEASE

2012
HOPP MICHAEL, TRENKWALDER CLAUDIA
openaire   +3 more sources